Search - tctmd.com

Displaying 221 - 240 of 292

Sort: Relevancy | Date

Presentation LAA 2014

Device-based LAA Closure 2014: From Indications to Worldwide Practice

Presenter: Saibal Kar

July 17, 2014

Presentation LAA 2014

LAA Ligation Using the LARIATTM Suture Delivery Device: Basic Technique and Keys to a Successful Result

Presenter: Jayanthi (Jay) N. Koneru

July 17, 2014

Presentation LAA 2014

LAA Closure: The Device, Attribute and Basic Technique- The Watchman Device -

Presenter: Saibal Kar

July 17, 2014

Presentation LAA 2014

Surgical Approaches to the LAA: Devices and Data

Presenter: Subhasis Chatterjee

July 17, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

Presentation

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

Presenter: David R. Holmes Jr.

June 30, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

Presentation EuroPCR 2014

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Presenter: Josep Rod?s-Cabau

May 20, 2014

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Presenter: Juan Granada

October 28, 2013

Presentation TCT 2013

Case #3: LAA Closure With a Novel Device

Presenter: Wolfgang Bocksch

October 28, 2013

Presentation TCT 2013

Next Generation Devices for Left Atrial Appendage Occlusion

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Presenter: Gerald Werner

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Presenter: Saibal Kar

October 28, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

Advertisement

Device-based LAA Closure 2014: From Indications to Worldwide Practice

LAA Ligation Using the LARIATTM Suture Delivery Device: Basic Technique and Keys to a Successful Result

LAA Closure: The Device, Attribute and Basic Technique- The Watchman Device -

Surgical Approaches to the LAA: Devices and Data

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

Benefit of LAA Closure Becomes Most Evident After 1 Year

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Case #3: LAA Closure With a Novel Device

Next Generation Devices for Left Atrial Appendage Occlusion

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content